Dr. Julie Stanton is one of four recipients of the 2018 Sandy Beaver Excellence in Teaching Award. These awards for excellence in teaching honor outstanding faculty in the Franklin College who have shown a sustained commitment to high-quality instruction.

A Toxoplasma gondii parasite with cytosolic Green fluorescent protein and the mitochondrial red fluorescent marker.

Dr. Silvia Moreno and her research team at the University of Georgia’s Center for Tropical & Emerging Global Diseases and Department of Cellular Biology are providing evidence that it is possible to develop a drug combination to target Toxoplasmosis that synergistically inhibits both host and parasite enzymes.

Dr. Kojo Mensa-Wilmot

The National Institutes of Health has awarded $2.6 million to University of Georgia researcher, Dr. Kojo Mensa-Wilmot, and his team to advance new drugs to treat African Trypanosomiasis, also known as HAT or African sleeping sickness.

The UGA-led team has developed a drug that has cured HAT in mice. "HAT is a disease of poverty,” says Dr. Mensa-Wilmot, ”so there is little incentive, understandably, for large pharmaceutical industries to be heavily invested.”